急性心肌梗死溶栓临床治疗体会  

Experience of clinical treatment of thrombolysis in acute myocardial infarction

作　　者：林威[1] 于东汇[1] 李东镐[1] 李中言[1] 

机构地区：[1]吉林医药学院附属医院,132013

出　　处：《中国实用医药》2012年第31期147-148,共2页China Practical Medicine

摘　　要：目的观察急性心肌梗死患者静脉溶栓治疗的临床疗效。方法回顾分析56例确诊为AMI且符合溶栓条件的患者进行溶栓以及规范化治疗的临床资料。结果 56例患者中32例发病6h内溶栓,其中29例溶解,3例未通;24例患者发病6-24h溶栓,其中16例溶解,8例未通。结论早期规范的溶栓治疗是治疗AMI的关键,尿激酶静脉溶栓治疗是恢复血管灌注的有效手段,价格便宜,安全、有效,值得临床推广。Objective To observe the effect of thrombolytic therapy in acute myocardial infarction clinical curative effect.Methods Retrospective analysis of 56 cases of AMI with thrombolysis conditions in patients with thrombolytic and standardized treatment of the clinical data.Results In the 56 patients,32 cases 6 h thrombolysis,including 29 cases of dissolution,3 cases did not pass;24 cases of 6-24 h therapy,including 16 cases of dissolution,8 cases did not pass.Conclusion The early specification of the thrombolytic therapy is the treatment of the key AMI,intravenous thrombolysis with urokinase in treatment is to restore vascular perfusion means effective,cheap,safe,effective,worthy of clinical application.

关 键 词：急性心肌梗死 尿激酶 静脉溶栓 

分 类 号：R542.22[医药卫生—心血管疾病]